🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2026-08-30
Trial ID
NCT07790419
Treatments Being Tested
This single arm, open label, single center, prospective study was designed ...
Status
Unknown
Location
Beijing Union Medical College Hospital
Start Date
2020-06-08
Trial ID
NCT04453930
Treatments Being Tested
In patients with locally advanced oral squamous cell carcinoma (OSCC), due ...
Status
Completed
Location
Shanghai Ninth People's Hospital
Start Date
2020-04-23
Trial ID
NCT04393506
Treatments Being Tested
This is a phase 2, single-arm clinical trial, with the purpose to evaluate ...
Status
Completed
Location
Chongqing University Cancer Hospital
Start Date
2022-01-01
Trial ID
NCT05213884
Treatments Being Tested
The efficacy and safety of HAIC combined with tyrosine kinase inhibitor and...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2021-11-05
Trial ID
NCT05135364
Treatments Being Tested
This is a prospective single-arm exploratory clinical study. The efficacy a...
Status
Recruiting
Location
Fujian Cancer Hospital
Start Date
2023-08-01
Trial ID
NCT05624099
Treatments Being Tested
According to the investigator's judgment, there are concomitant diseases th...
Status
Unknown
Location
Shengjing Hospital of China Medical University
Start Date
2021-09-07
Trial ID
NCT05070598
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Start Date
2026-05-13
Trial ID
NCT07645209
Treatments Being Tested
This prospective trial aims to enroll patients with high-risk stage III-IVA...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2023-10-09
Trial ID
NCT06092957
This study aims to evaluate the efficacy and safety of camrelizumab in comb...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2024-03
Trial ID
NCT06313463
Treatments Being Tested